Document Reviewers b, Petr Widimsky, Philippe Kolh, Stefan Agewall, Héctor Bueno,
Antonio Coca, Gert J. De Borst, Victoria Delgado, Florian Dick, Cetin Erol, Marc Ferrini …

A formal systematic review and study-level meta-analysis of randomized controlled trials
investigating treatment of the infrapopliteal arteries with paclitaxel-coated balloons …

W 2011 roku ESC opublikowało pierwsze wytyczne dotyczące rozpoznawania i leczenia
chorób tętnic obwodowych (PAD)[1]. Ta publikacja wypełniła ważną lukę wśród wytycznych …

Objective: Hmox1 (heme oxygenase-1) is a stress-induced enzyme that catalyzes the
degradation of heme to carbon monoxide, iron, and biliverdin. Induction of Hmox1 and its …

With a rise in the aging popluation, the prevalence of peripheral arterial disease (PAD) is
markedly increasing. The overall disease prevalence of PAD is in the range of 3%-10 …

Lower-extremity arterial disease (LEAD) is a major endemic disease with an alarming
increased prevalence worldwide. It is a common and severe condition with excess risk of …

There are> 12 million patients with peripheral artery disease in the United States. The most
severe form of peripheral artery disease is critical limb ischemia (CLI). The diagnosis and …

Objective Accurate survival prediction critically influences decision-making in caring for
patients with chronic limb-threatening ischemia (CLTI). The Bypass versus Angioplasty in …

Peripheral artery disease (PAD) of the lower extremities is a common manifestation of
atherosclerosis that is increasing in global prevalence and in the associated public health …

Critical limb ischemia (CLI) constitutes the most severe form of peripheral arterial disease
(PAD), it is characterized by progressive blockade of arterial vessels, commonly correlated …